Career history of Martin Everett
Former positions of Martin Everett
| Companies | Position | Start | End |
|---|---|---|---|
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Corporate Officer/Principal | - | - |
| University of Birmingham | Corporate Officer/Principal | - | - |
MerLion Pharmaceuticals Pte Ltd.
 MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Chief Tech/Sci/R&D Officer | 2009-10-25 | - |
Training of Martin Everett
| University of Wales, Newport | Undergraduate Degree |
| University of Bristol | Doctorate Degree |
Statistics
International
| United Kingdom | 5 |
| Germany | 2 |
Operational
| Corporate Officer/Principal | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Consumer Services | 4 |
| Commercial Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 2 |
|---|---|
MerLion Pharmaceuticals Pte Ltd.
MerLion Pharmaceuticals Pte Ltd. Miscellaneous Commercial ServicesCommercial Services MerLion Pharmaceuticals Pte Ltd. provides drug discovery and development services. It focuses on developing its lead antibacterial candidate, finafloxacin, through early and mid-stage clinical trials. The company was founded in 2002 and is headquartered in Singapore. | Commercial Services |
| Glaxo Smithkline Plc /Clinical Pharmacology Unit/ | Commercial Services |
- Stock Market
- Insiders
- Martin Everett
- Experience
